S&P 500   3,134.19 (+0.19%)
DOW   27,104.07 (+0.08%)
QQQ   216.95 (+0.73%)
AAPL   294.18 (+2.12%)
FB   198.17 (+0.71%)
MSFT   170.78 (+1.61%)
GOOGL   1,394.08 (+0.56%)
AMZN   1,980.00 (+0.37%)
CGC   20.05 (+2.19%)
NVDA   269.76 (+2.94%)
BABA   209.49 (+1.89%)
MU   52.74 (+1.21%)
GE   11.07 (-2.21%)
TSLA   791.98 (-0.99%)
AMD   47.86 (+0.61%)
T   37.38 (+0.08%)
F   7.30 (+0.83%)
NFLX   378.42 (+5.09%)
BAC   30.85 (-0.74%)
DIS   123.92 (-3.33%)
GILD   72.86 (+3.94%)
S&P 500   3,134.19 (+0.19%)
DOW   27,104.07 (+0.08%)
QQQ   216.95 (+0.73%)
AAPL   294.18 (+2.12%)
FB   198.17 (+0.71%)
MSFT   170.78 (+1.61%)
GOOGL   1,394.08 (+0.56%)
AMZN   1,980.00 (+0.37%)
CGC   20.05 (+2.19%)
NVDA   269.76 (+2.94%)
BABA   209.49 (+1.89%)
MU   52.74 (+1.21%)
GE   11.07 (-2.21%)
TSLA   791.98 (-0.99%)
AMD   47.86 (+0.61%)
T   37.38 (+0.08%)
F   7.30 (+0.83%)
NFLX   378.42 (+5.09%)
BAC   30.85 (-0.74%)
DIS   123.92 (-3.33%)
GILD   72.86 (+3.94%)
S&P 500   3,134.19 (+0.19%)
DOW   27,104.07 (+0.08%)
QQQ   216.95 (+0.73%)
AAPL   294.18 (+2.12%)
FB   198.17 (+0.71%)
MSFT   170.78 (+1.61%)
GOOGL   1,394.08 (+0.56%)
AMZN   1,980.00 (+0.37%)
CGC   20.05 (+2.19%)
NVDA   269.76 (+2.94%)
BABA   209.49 (+1.89%)
MU   52.74 (+1.21%)
GE   11.07 (-2.21%)
TSLA   791.98 (-0.99%)
AMD   47.86 (+0.61%)
T   37.38 (+0.08%)
F   7.30 (+0.83%)
NFLX   378.42 (+5.09%)
BAC   30.85 (-0.74%)
DIS   123.92 (-3.33%)
GILD   72.86 (+3.94%)
S&P 500   3,134.19 (+0.19%)
DOW   27,104.07 (+0.08%)
QQQ   216.95 (+0.73%)
AAPL   294.18 (+2.12%)
FB   198.17 (+0.71%)
MSFT   170.78 (+1.61%)
GOOGL   1,394.08 (+0.56%)
AMZN   1,980.00 (+0.37%)
CGC   20.05 (+2.19%)
NVDA   269.76 (+2.94%)
BABA   209.49 (+1.89%)
MU   52.74 (+1.21%)
GE   11.07 (-2.21%)
TSLA   791.98 (-0.99%)
AMD   47.86 (+0.61%)
T   37.38 (+0.08%)
F   7.30 (+0.83%)
NFLX   378.42 (+5.09%)
BAC   30.85 (-0.74%)
DIS   123.92 (-3.33%)
GILD   72.86 (+3.94%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 PTC TherapeuticsTaro Pharmaceutical IndustriesBlueprint MedicinesMyokardiaZai Lab
SymbolNASDAQ:PTCTNYSE:TARONASDAQ:BPMCNASDAQ:MYOKNASDAQ:ZLAB
Price Information
Current Price$53.80$73.68$58.32$64.68$57.72
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$60.50$94.00$104.08$85.40$52.89
% Upside from Price Target12.45% upside27.58% upside78.47% upside32.03% upside-8.38% downside
Trade Information
Market Cap$3.38 billion$2.82 billion$3.18 billion$3.00 billion$3.26 billion
Beta1.970.61.652.091.34
Average Volume936,38543,508732,448330,152416,088
Sales & Book Value
Annual Revenue$264.73 million$669.89 million$66.51 million$33.56 million$130,000.00
Price / Sales12.524.2147.3889.1025,796.40
CashflowN/A$7.79 per shareN/AN/AN/A
Price / CashN/A9.46N/AN/AN/A
Book Value$6.12 per share$54.07 per share$8.59 per share$9.20 per share$4.32 per share
Price / Book8.791.366.797.0313.36
Profitability
Net Income$-128,080,000.00$281.78 million$-347,690,000.00$-67,700,000.00$-139,070,000.00
EPS($1.84)$7.23($7.27)($1.76)($2.64)
Trailing P/E RatioN/A11.41N/AN/AN/A
Forward P/E RatioN/A10.51N/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-74.86%38.24%-522.75%N/AN/A
Return on Equity (ROE)-31.92%12.45%-72.52%-30.34%N/A
Return on Assets (ROA)-12.06%11.23%-49.72%-28.29%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.44%N/A0.19%N/AN/A
Current Ratio4.40%6.81%4.85%9.63%8.02%
Quick Ratio4.30%6.07%4.85%9.63%8.00%
Ownership Information
Institutional Ownership PercentageN/A11.00%92.02%N/A62.63%
Insider Ownership Percentage7.00%13.80%4.02%4.30%N/A
Miscellaneous
Employees5111,464217165309
Shares Outstanding61.63 million38.26 million54.03 million46.23 million58.10 million
Next Earnings Date3/2/2020 (Confirmed)5/27/2020 (Estimated)5/14/2020 (Estimated)2/27/2020 (Confirmed)3/5/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel